These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35450036)

  • 1. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.
    Negrea G; Rauca VF; Meszaros MS; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Muntean D; Sesarman A; Banciu M
    Front Pharmacol; 2022; 13():870347. PubMed ID: 35450036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
    Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
    Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
    Rauca VF; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Mot AC; Rakosy-Tican E; Sesarman A; Banciu M
    Sci Rep; 2021 Nov; 11(1):22102. PubMed ID: 34764332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis
    Sesarman A; Luput L; Rauca VF; Patras L; Licarete E; Meszaros MS; Dume BR; Negrea G; Toma VA; Muntean D; Porfire A; Banciu M
    J Liposome Res; 2024 Dec; 34(4):535-546. PubMed ID: 38379249
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Luput L; Licarete E; Drotar DM; Nagy AL; Sesarman A; Patras L; Rauca VF; Porfire A; Muntean D; Achim M; Tomuta I; Vlase L; Catoi C; Dragos N; Banciu M
    J Cancer; 2018; 9(2):440-449. PubMed ID: 29344291
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.
    Rauca VF; Licarete E; Luput L; Sesarman A; Patras L; Bulzu P; Rakosy-Tican E; Banciu M
    PLoS One; 2018; 13(8):e0202827. PubMed ID: 30138430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma
    Patras L; Ionescu AE; Munteanu C; Hajdu R; Kosa A; Porfire A; Licarete E; Rauca VF; Sesarman A; Luput L; Bulzu P; Chiroi P; Tranca RA; Meszaros MS; Negrea G; Barbu-Tudoran L; Potara M; Szedlacsek S; Banciu M
    Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 34964693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment.
    Licarete E; Rauca VF; Luput L; Drotar D; Stejerean I; Patras L; Dume B; Toma VA; Porfire A; Gherman C; Sesarman A; Banciu M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress.
    Alupei MC; Licarete E; Patras L; Banciu M
    Cancer Lett; 2015 Jan; 356(2 Pt B):946-52. PubMed ID: 25444912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
    Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5-fluorouracil in vivo.
    Luput L; Sesarman A; Porfire A; Achim M; Muntean D; Casian T; Patras L; Rauca VF; Drotar DM; Stejerean I; Tomuta I; Vlase L; Dragos N; Toma VA; Licarete E; Banciu M
    Cancer Sci; 2020 Apr; 111(4):1344-1356. PubMed ID: 31960547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
    Banciu M; Metselaar JM; Schiffelers RM; Storm G
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):101-10. PubMed ID: 18602825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil.
    Banciu M; Schiffelers RM; Storm G
    Pharm Res; 2008 Aug; 25(8):1948-55. PubMed ID: 18523874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia.
    Licarete E; Sesarman A; Rauca VF; Luput L; Patras L; Banciu M
    Oncol Lett; 2017 May; 13(5):3942-3950. PubMed ID: 28521491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells.
    Sesarman A; Tefas L; Sylvester B; Licarete E; Rauca V; Luput L; Patras L; Banciu M; Porfire A
    Pharmacol Rep; 2018 Apr; 70(2):331-339. PubMed ID: 29477042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herceptin-conjugated liposomes co-loaded with doxorubicin and simvastatin in targeted prostate cancer therapy.
    Li N; Xie X; Hu Y; He H; Fu X; Fang T; Li C
    Am J Transl Res; 2019; 11(3):1255-1269. PubMed ID: 30972160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
    Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
    Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.